196 Results

People

  1. De Angelis
    De Angelis
  2. Kelsen
    Kelsen
  3. O'Reilly
    O'Reilly
  4. Hudis
    Hudis
  5. Amar
    Amar
  6. Ilson
    Ilson
  7. Kelly
    Kelly
  8. Aghajanian
    Aghajanian
  9. Shah
    Shah
  10. Saltz
    Saltz

Groups

  1. Department of Medicine (108)
  2. Solid Tumor Oncology Division (82)
  3. Surgery (37)
  4. Survivorship Research (32)
  5. Gastrointestinal Oncology Service (30)
  6. Hematologic Malignancies, Division of (29)
  7. Epidemiology and Biostatistics (23)
  8. Center for Hematologic Malignancies (21)
  9. Center for Pancreatic Cancer Research (19)
  10. Genitourinary Oncology Service (19)
  1. "thromboembolism"
Formats
  1. Journal Article (181)
  2. Review (9)
  3. Editorial (2)
  4. Book Section (1)
  5. Correspondence (1)
  6. Guidelines (1)
  7. Meeting Abstract (1)
Groups
  1. Department of Medicine (108)
  2. Solid Tumor Oncology Division (82)
  3. Surgery (37)
  4. Survivorship Research (32)
  5. Gastrointestinal Oncology Service (30)
  6. Hematologic Malignancies, Division of (29)

More Groups

People
  1. David Kelsen (10)
  2. Eileen O'Reilly (10)
  3. Lisa De Angelis (10)
  4. Clifford Hudis (9)
  5. David Amar (8)
  6. David Ilson (8)

More People

Years
  1. 2025 (3)
  2. 2024 (12)
  3. 2023 (7)
  4. 2022 (5)
  5. 2021 (6)
  6. 2020 (2)

More Years

Publications
  1. Cancer (12)
  2. Gynecologic Oncology (12)
  3. Journal of Clinical Oncology (10)
  4. Journal of the National Comprehensive Cancer Network (10)
  5. European Urology (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (41)
  2. Wiley Blackwell (22)
  3. Elsevier Science, Inc. (20)
  4. Springer (15)
  5. Oxford University Press (13)
  6. American Society of Clinical Oncology (10)

More Publishers

Results (196)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer
    Journal Article

    Andres, S.; Finch, L.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Jang, D.; O'Cearbhaill, R.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis
    Journal Article

    Costa, B. A.; Costa, T. A.; Saravia, S. D.; Felix, N.; Tan, C. R.; Korde, N.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients
    Review

    Ranjan, S.; Leung, D.; Ghiaseddin, A. P.; Taylor, J. W.; Lobbous, M.; Dhawan, A.; Budhu, J. A.; Coffee, E.; Melnick, K.; Chowdhary, S. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Cancer and arterial thrombosis: Therapeutic options
    Review

    Cheong, M. A.; Leader, A.
    Research and Practice in Thrombosis and Haemostasis (2024)

    Fulltext@MSK | Save
  • Ischemic stroke in cancer: Mechanisms, biomarkers, and implications for treatment
    Review

    Costamagna, G.; Navi, B. B.; Beyeler, M.; Hottinger, A. F.; Alberio, L.; Michel, P.
    Seminars in Thrombosis and Hemostasis (2024)

    Fulltext@MSK | Save
  • Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up☆
    Guidelines

    Conroy, T.; Pfeiffer, P.; Vilgrain, V.; Lamarca, A.; Seufferlein, T.; O'Reilly, E. M.; Hackert, T.; Golan, T.; Prager, G.; Haustermans, K.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Systemic anticancer therapy and thromboembolic outcomes in hospitalized patients with cancer and COVID-19
    Journal Article

    Gulati, S.; Hsu, C. Y.; Shah, S.; Shah, P. K.; Zon, R.; Alsamarai, S.; Awosika, J.; El-Bakouny, Z.; Bashir, B.; Beeghly, A.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Prospective feasibility and phase 1/2 trial of preoperative proton beam therapy with concurrent chemotherapy for resectable stage IIIA or superior sulcus non-small cell lung cancer
    Journal Article

    Simone, C. B. 2nd; Yegya-Raman, N.; Manjunath, S.; Verma, V.; Shabason, J. E.; Xu, L.; Cengel, K. A.; Levin, W. P.; Berman, A. T.; Christodouleas, J. P.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Journal Article

    Rimner, A.; Moore, Z. R.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Abdulnour, R. E. E.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Cuaron, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save